Omalizumab-associated anaphylactic reactions reported between January 2007 and June 2008

Annals of Allergy, Asthma and Immunology

Volumn 103, Issue 5, 2009, Pages 442-445

  Lin, Robert Y ^a,b   Rodriguez Baez, Gerson ^a   Bhargave, Geeta A ^a  

^a ST VINCENT S HOSPITAL MANHATTAN   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; CORTICOSTEROID; OMALIZUMAB; ANTIASTHMATIC AGENT; MONOCLONAL ANTIBODY;

ADULT; ALLERGIC REACTION; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTHRITIS; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTASIS; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; EDEMA; FEMALE; FEVER; FLUSHING; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; HERPES ZOSTER; HOSPITAL ADMISSION; HUMAN; INTESTINE OBSTRUCTION; LARYNX EDEMA; LIP EDEMA; LIP SWELLING; MAJOR CLINICAL STUDY; MALE; PHARYNX EDEMA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SERUM SICKNESS; SIDE EFFECT; SKIN DISEASE; THROAT SWELLING; TONGUE EDEMA; TONGUE SWELLING; URTICARIA; ASTHMA; IMMUNOLOGY; UNITED STATES;

ADULT; ANAPHYLAXIS; ANTI-ASTHMATIC AGENTS; ANTIBODIES, MONOCLONAL; ASTHMA; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; UNITED STATES;

EID: 73349096020     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60366-3     Document Type: Article

References (15)

1. Prenner BM. Asthma 2008: targeting immunoglobulin E to achieve disease control. J Asthma. 2008;45:429-436.
2. Limb SL, Starke PR, Lee CE, Chowdhury BA. Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma. J Allergy Clin Immunol. 2007;120:1378 -1381.
3. Price KS, Hamilton RG. Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy. Allergy Asthma Proc. 2007;28:313-319.
4. Omalizumab: new drug; asthma: too many unknowns for an anti-IgE. Prescrire Int. 2007;16:179 -182.
5. Kivitz A, Cohen S, Dowd JE, et al. Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial. Clin Ther. 2006;28:1619 -1629.
6. Cox L, Platts-Mills TA, Finegold I, et al; American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma and Immunology. American Academy of Allergy, Asthma & Immunology/ American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis. J Allergy Clin Immunol. 2007;120:1373-1377.
7. Genentech Inc. Xolair (omalizumab): full prescribing information. 2007. http://www.gene.com/gene/products/information/pdf/xolair-prescribing. pdf. Accessed September 24, 2007.
8. Barry PJ, O'Mahony A, Finnegan C, O'Connor TM. Delayed allergic reactions to omalizumab: are patients reporting all cases? J Allergy Clin Immunol. 2008;121:785-786.
9. The Adverse Event Reporting System (AERS) latest quarterly data files. http://www.fda.gov/cder/aers/extract.htm. Accessed September 27, 2008.
10. Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. 1999;20:109 -117.
11. Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117:391-397.
12. Borchers AT, Keen CL, Gershwin ME. Fatalities following allergen immunotherapy. Clin Rev Allergy Immunol. 2004;27:147-158.
13. Kontou-Fili K. High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis. Allergy. 2008;63:376 -378.
14. MedDRA® term selection: points to consider. Release 3.6 based on MedDRA version 9.0. http://www.meddramsso.com/MSSOWeb/ document-library/ ptccoding3.6.pdf. Accessed September 27, 2008.
15. Greenberg MA, Kaufman CR, Gonzalez GE, Trusewych ZP, Rosenblatt CD, Summers RJ. Late and immediate systemic-allergic reactions to inhalant allergen immunotherapy. J Allergy Clin Immunol. 1986;77: 865-870.